The times they are a-changing. The people have spoken. The politicians have spoken. Industry has spoken.
Everyone has spoken.
There aren’t too many industries where everyone has a view. Ask people about tech stocks; some know about them. Some don’t.
Ask people about mining stocks. Some people know about them. Some don’t.
But ask people about cannabis? Suddenly, everyone has a view.
And it’s polarising. People either understand the benefits, or they demonise the plant and the industry.
There aren’t too many people who don’t have a view on cannabis. That’s both good and bad. The good side is that it clearly engages with people. It makes them think about it, be aware of it. The bad side is there’s a lot of misinformation out there.
And often the wrong information is worse than no information.
But when you get the right information, it can transform your views. And after decades of disinformation, things are now starting to change.
No longer is marijuana the ‘devils lettuce’. Now it’s starting to become ‘nature’s wonder drug’.
The volume of research and development going into the legal marijuana industry is massive.
Billion dollar companies like Canopy Growth, Aurora Cannabis and GW Pharmaceuticals are pushing the industry forward at breakneck speed.
And it’s starting to affect the views of governments around the world.
We’re aware there are countries opening their doors to legal marijuana. Many are starting with legal medicinal marijuana. And some — like Uruguay, much of the US and now Canada — are going with legal recreational marijuana, as well.
The Canadian opportunity is massive. And we’ve gone to extreme lengths to find the best Canadian companies involved in this space. In fact, we’ve even uncovered an Aussie, ASX-listed stock that’s set to skyrocket from Canada’s legal weed laws.
But there are a couple of other big markets that could see the industry explode in value.
One is the US. Now we know there’s a system for the legalisation of medicinal marijuana. And in some states like California and Colorado, recreational weed is being legalised.
But now we’re seeing the states open up access like never before. The federal system is still a maze. They still list marijuana as a Schedule A drug, on the same level as heroin and cocaine.
Some of the states, however, are opening access to legal medical weed like never before.
In South Carolina an advisory vote won with a ‘landslide victory’ for access to legal weed.
According to The State,
‘The question “Do you support passing a state law allowing doctors to prescribe medical marijuana to patients?” was approved by Democrats in all of the state’s 46 counties during Tuesday’s primary.’
The article continues:
‘Also on Tuesday, a key U.S. Senate subcommittee moved to include protections for state marijuana laws in a funding bill for the Justice Department.’
This is another huge leap forward for easy access to legal weed in the US. We believe it’s only a matter of time until there’s an easy-access federal system.
We anticipate that with Canada legalising the entire cannabis market, the US will soon follow.
Once the US sees the economic benefits of this industry, they’ll be fighting to pass federal laws. When that happens, expect the biggest boom in marijuana stocks we’ve ever seen.
This week in Markets & Money
Stuck in traffic? A flying car could be the answer you were looking for. As the global population and traffic congestion grows, a few players are finding a solution. And turning fanciful science fiction into reality. Click here to read Monday’s story from Selva Freigedo.
Are we on the brink of a total trade war? Tension builds between the US and Canada, and China takes a more globalised approach. Read why in Tuesday’s article.
It’s every millennial’s dream. Avocados are down in price, and so is property. For the first time in five years, first-home buyers can have their smashed avo and eat it too. Read why in Selva’s article from Wednesday, here.
Interest rates have gone up and are expected to only go higher. Raised inflation and higher, less productive debt levels could be on the horizon. The worst isn’t over yet. Read more in Thursday’s story here.
Despite efforts to revive the European economy through Quantitative Easing, savers are still feeling the impact of low long-term interest rates. Why? Read Selva’s Friday article, here, to find out.